Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Oracle Corporation

ORCL
Technology · Software - Infrastructure

Oracle Corporation's earnings have outrun its stock. EPS grew +34.3% in a year against a −40.4% price move.

The sharpest disagreement: annual EPS moved +34.3% against a −40.4% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (9 weeks in) while the P/E sits at the 3rd percentile of its own 4-year range. Underneath, the last four quarters read improving — profit +25.4% year on year, and 179% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Mixed
fundamental trajectory, 12 quarters
Price
$146
−40.4% 1Y
P/E
25.0×
3rd pctile
of its own 4-year range
Revenue (May 26)
$19.2 B
+20.6% YoY
Profit (May 26)
$4.3 B
+25.4% YoY
Operating margin
32.0%
−0.1 pp YoY
ROE
53%
FY26
ROIC
11.5%
vs WACC 10.5% → +1.0 pp
Cash conversion
179%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Oracle Corporation trades at $146, in a downtrend and 9 weeks into that stage. That is −19.7% against its own 200-day average. It sits at 16% of a 52-week range of $115 to $309. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (7 weeks and counting).

Today the stock is in a downtrend — week 9 of stage 4. At $146 it trades −19.7% versus its 200-day average and sits at 16% of its 52-week range ($115–$309).

Aug 26: $146 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−19.7% versus the 200-day line, week 9 of stage 4
Price50-day avg200-day avg
S2S2S1S2S1$326$263$201$138$75.0$$146$182Jul 23Apr 24Jan 25Oct 25Aug 26
S2S2S1S2S1$326$263$201$138$75.0$$146$182Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (527 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Aug 26

Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +257% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-06-18) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Oracle Corporation trades at 25.0× P/E, near the bottom of its own range — cheaper only 3% of the time. Its long-run median P/E is 34.3×, measured across 4.2 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 25.0× is near the bottom of its own range — cheaper only 3% of the time, against a long-run median of 34.3× measured over 4.2 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 25.0× vs a 34.3× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 4.2-year window; loss-period spikes above 66× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 3% of the time
P/EMedianEPS (TTM) (quarterly)
69.9×$6.356.4×$4.743.0×$3.129.5×$1.616.0×$0.0×$25.00×$6Jun 22Jun 23Jul 24Jul 25Aug 26
69.9×$6.356.4×$4.743.0×$3.129.5×$1.616.0×$0.0×$25.00×$6Jun 22Jul 24Aug 26
PEG 1.28 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 19 quarters.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
2.9×2.3×1.8×1.3×0.8××1.28×Nov 21Nov 22Feb 24Feb 25May 26
2.9×2.3×1.8×1.3×0.8××1.28×Nov 21Feb 24May 26
P/E
25.0×
3rd percentile of 4y
PEG
0.64
as reported

Why the multiple sits where it does: over the past year annual EPS moved +34.3% against a −40.4% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 3y, of the +8.4%/yr price move, ~+24.0%/yr came from earnings growth and ~−15.6 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Oracle Corporation reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 11.6% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +17.4% in FY26, profit +37.4% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
19%39%15%33%12%27%8.5%21%5.1%15%%%17.4%37.4%FY22FY24FY26
19%39%15%33%12%27%8.5%21%5.1%15%%%17.4%37.4%FY22FY24FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
18%65%15%51%11%36%8.1%22%4.7%7.3%%%17.4%37.2%34.3%Aug 23Nov 24May 26
18%65%15%51%11%36%8.1%22%4.7%7.3%%%17.4%37.2%34.3%Aug 23Nov 24May 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
15%14%13%12%11%%11.6%Aug 23Feb 24Nov 24Aug 25May 26
15%14%13%12%11%%11.6%Aug 23Nov 24May 26
Revenue growth
Steady high
latest +17.4% · span +5.6% to +17.4%
Profit growth
Rising
latest +37.2% · span +13.5% to +61.4%
EPS growth
Rising
latest +34.3% · span +11.3% to +60.0%
ROCE
Falling
latest 11.6% · span 11.6%–14.5%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+17.4%+10.5%
Profit+37.4%+26.2%
EPS+34.3%+23.8%
Stock price−40.4%+8.4%+10.2%+13.5%
Revenue YoY (May 26)
+20.6%
latest quarter vs a year ago
Profit YoY (May 26)
+25.4%
latest quarter vs a year ago
Revenue 10y
12.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

42.2/100 — rank 22 of 28 in Software - Infrastructure · 85% evidence confidence

Oracle Corporation scores 42.2 out of 100 against the 28 companies it is compared with in Software - Infrastructure, ranking 22. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 16.1 + 13.1 + 12.4 + 0.6 = 42.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Oracle Corporation reported $19.2 B of revenue in the May 26 quarter, +20.6% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 12.2% a year. The last full year, FY26, came in at $67.4 B. The last four reported quarters add to $67.4 B.

FY26 revenue came in at $67.4 B (+17.4% on the year), capping 4 years at 12.2% compound. The latest quarter (May 26) printed $19.2 B, +20.6% year on year — the 12th consecutive quarter of year-over-year growth.

FY26 revenue $67.4 B (+17.4% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
12.2% a year over 4 years
RevenueYoY growth
7319%5515%3612%188.5%0.05.1%$ B%$67B17.4%FY22FY24FY26
7319%5515%3612%188.5%0.05.1%$ B%$67B17.4%FY22FY24FY26
May 26: $19.2 B (+20.6% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
2123%1618%1013%5.27.2%0.01.8%$ B%$19B20.6%Aug 23Nov 24May 26
2123%1618%1013%5.27.2%0.01.8%$ B%$19B20.6%Aug 23Nov 24May 26

Pace check: the last four quarters averaged +17.2% growth against the decade's 12.2% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +17.4% over the last 4 quarters against +12.8%/yr over the last 8 — accelerating; TTM profit +37.2% vs +27.8%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Oracle Corporation's operating margin is 32.0% in the May 26 quarter, −0.1 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 25.8% to 30.8%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 32.0%, −0.1 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 25.8%–30.8%.

🚨 Why the margin moved: operating margin went −0.1 pp year on year while gross margin went −5.0 pp — the loss came mostly from the gross line: input costs and pricing.

FY26: 30.6% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a 25.8–30.8% band over 5 years
operating marginYoY change (pp)
31%3.0%30%2.2%28%1.3%27%0.4%25%−0.4%%%30.6%−0.2%FY22FY24FY26
31%3.0%30%2.2%28%1.3%27%0.4%25%−0.4%%%30.6%−0.2%FY22FY24FY26
May 26: 32.0% operating margin (−0.1 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
33%4.0%31%2.6%30%1.1%28%−0.3%26%−1.7%%%32%−0.1%Aug 23Nov 24May 26
33%4.0%31%2.6%30%1.1%28%−0.3%26%−1.7%%%32%−0.1%Aug 23Nov 24May 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Oracle Corporation earned $4.3 B of net profit in the May 26 quarter, +25.4% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was $17.1 B. The 4-year compound rate is 26.3%. That is 22.4% of the quarter's revenue. The same quarter a year earlier earned $3.4 B.

May 26 profit was $4.3 B, +25.4% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed $17.1 B (+37.4%), and the 4-year compound rate is 26.3%.

FY26 profit $17.1 B (+37.4% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
26.3% a year over 4 years
Net profitYoY growth
1839%1433%9.228%4.623%0.017%$ B%$17B37.4%FY22FY24FY26
1839%1433%9.228%4.623%0.017%$ B%$17B37.4%FY22FY24FY26
May 26: $4.3 B (+25.4% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
3rd straight quarter of growth
Net profit (quarterly)YoY growth
6.6103%5.074%3.345%1.716%0.0−13%$ B%$4B25.4%Aug 23Nov 24May 26
6.6103%5.074%3.345%1.716%0.0−13%$ B%$4B25.4%Aug 23Nov 24May 26

Why profit moved: revenue contributed +20.6% and the margin −0.1 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +36.6% vs revenue +17.2%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 179% of Oracle Corporation's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $32.0 B of operating cash against $17.1 B of profit. After $55.7 B of capital spending, $−23.7 B was left as free cash.

FY26: operating cash of $32.0 B against reported profit of $17.1 B, leaving free cash of $−23.7 B after $55.7 B of capital spending. Across the last 3 fiscal years the conversion rate is 179% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO $32.0 B vs profit $17.1 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
179% of 3-year profit arrived as cash
Operating cashNet profitFree cash
36204.1−12−28$ B$32B$17B$−24BFY22FY24FY26
36204.1−12−28$ B$32B$17B$−24BFY22FY24FY26
May 26: operating cash $14.6 B = 340% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
16367%12270%7.9173%3.976%0.0−21%$ B%$15B340%Aug 23Nov 24May 26
16367%12270%7.9173%3.976%0.0−21%$ B%$15B340%Aug 23Nov 24May 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Oracle Corporation does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $84.0 B over the last 3 years. Averaged over those years that is 41.6% of FY26 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $84.0 B over the last 3 fiscal years.

FY26: capex $55.7 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
604530150.0$ B$56BFY22FY24FY26
604530150.0$ B$56BFY22FY24FY26
May 26: capex $16.5 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
207.0152.110−2.95.0−7.90.0−13$ B$ B$17B$−2BAug 23Nov 24May 26
207.0152.110−2.95.0−7.90.0−13$ B$ B$17B$−2BAug 23Nov 24May 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Oracle Corporation earns a ROE of 40% in FY26. That is up from a trough of −117% in FY22. Return on invested capital clears the cost of that capital by +1.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 25.4% net margin on 0.26× asset turns.

FY26 ROE is 40%, recovered from a FY22 trough of −117% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 25.4% net margin × 0.26× asset turns × 6.08× balance-sheet leverage ≈ 40.2% on equity. Margin is doing the heavy lifting; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 11.5% − 10.5% = a +1.0 pp spread. The 10.5% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

FY26: ROE 40% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 10.5% cost of capital used on this page.
the climb back from FY22's −117%
ROEROIC (annual)WACC
598%406%214%22%−169%%39.7%12.8%FY22FY24FY26
598%406%214%22%−169%%39.7%12.8%FY22FY24FY26
May 26: ROIC 13.0% (TTM) vs WACC 10.5% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
1,160%739%319%−102%−523%%13%70.4%Aug 23Nov 24May 26
1,160%739%319%−102%−523%%13%70.4%Aug 23Nov 24May 26
11 · Dividend

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

Oracle Corporation paid $2.00 per share over the last four reported quarters, up 25.0% on a year ago. The most recent declaration was $0.50 for May 26. Against the current price of $146 that is a trailing yield of 1.37%, measured on dividends already paid rather than on a forecast.

Oracle Corporation paid $2.00 per share across the last four reported quarters, most recently $0.50 for May 26. That is up 25.0% against the same quarter a year earlier. Against the current price of $146 the trailing twelve months work out to 1.37% — trailing dividends measured against today's price, not a forward estimate.

Dividend per share by quarter Declared dividend per share, $ B, per reported quarter. 12 quarters on file.
latest $0.50 (May 26)
Dividend per share
0.50.40.30.10.0$ B$1BAug 23Feb 24Nov 24Aug 25May 26
0.50.40.30.10.0$ B$1BAug 23Nov 24May 26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Oracle Corporation carries total debt of $156 B against shareholder equity of $43.1 B as of May 26, a debt-to-equity of 3.63. On the annual view that ratio went from −13.15 in FY22 to 3.63 in FY26. Read the returns elsewhere on this page with that leverage in mind.

May 26: total debt of $156 B against shareholder equity of $43.1 B — a debt-to-equity of 3.63. On the annual view, debt-to-equity went from −13.15 (FY22) to 3.63 (FY26). Read the returns on this page with that leverage in mind.

FY26: debt $156 B at 3.63× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
16963.7×12743.1×8422.4×421.8×0.0−18.8×$ B×$156B3.63×FY22FY24FY26
16963.7×12743.1×8422.4×421.8×0.0−18.8×$ B×$156B3.63×FY22FY24FY26
May 26: debt $156 B, debt-to-equity 3.63 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
16933.5×12725.5×8417.5×429.4×0.01.4×$ B×$156B3.63×Aug 23Nov 24May 26
16933.5×12725.5×8417.5×429.4×0.01.4×$ B×$156B3.63×Aug 23Nov 24May 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

2.9% of Oracle Corporation's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 1.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 2.9% of the float is sold short, and at typical trading volumes it would take about 1.4 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
2.9%
of the tradable float
Days to cover
1.4
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Oracle Corporation: the Z-score reads 2.18. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 2.18 sits in the grey band — neither clearly safe nor clearly distressed.

The safety line in one sentence: the Z-score reads 2.18.

15 · Related companies · Software - Infrastructure
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Fortinet, Inc.FTNT 67.2/100Thin evidence · provisional58% evidence LEADER 21.4/35 Revenue — · PAT — · OPM change 1.9 pp 45% evidence 17.8/25 ROCE 11.6% · OPM 31.4% 76% evidence 9.4/20 P/E 54.1× · PEG — 15% evidence 18.6/20 RS sector 39.5% · RS bench 54.1% · 1Y 126.2%12 of 12 weeks ahead 100% evidence
Exact sum: 21.4 + 17.8 + 9.4 + 18.6 = 67.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2NetApp, Inc.NTAP 65.4/100Favorable setup85% evidence LEADER 19.4/35 Revenue 5.4% · PAT 7.6% · OPM change 7.2 pp 95% evidence 16.1/25 ROCE 8.3% · OPM 27.3% 76% evidence 11.9/20 P/E 17.1× · PEG 1.43 65% evidence 18.0/20 RS sector 27.3% · RS bench 40.7% · 1Y 79.3%12 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 16.1 + 11.9 + 18 = 65.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Corpay, Inc.CPAY 62.9/100Mixed-positive evidence81% evidence BREAKING OUT 21.9/35 Revenue 18.2% · PAT 16.1% · OPM change 7.9 pp 83% evidence 15.2/25 ROCE 5.8% · OPM 50.4% 76% evidence 14.3/20 P/E 17.4× · PEG 1.01 65% evidence 11.5/20 RS sector -0.1% · RS bench 11.2% · 1Y 31.4%5 of 12 weeks ahead 100% evidence
Exact sum: 21.9 + 15.2 + 14.3 + 11.5 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4VeriSign, Inc.VRSN 60.5/100Thin evidence · provisional58% evidence BASING 22.2/35 Revenue — · PAT — · OPM change 1.1 pp 45% evidence 21.6/25 ROCE 1141.8% · OPM 68.5% 76% evidence 10.6/20 P/E 27.3× · PEG — 15% evidence 6.1/20 RS sector -7.4% · RS bench 2.9% · 1Y 10%4 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 21.6 + 10.6 + 6.1 = 60.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Palantir Technologies Inc.PLTR 60.0/100Mixed-positive evidence71% evidence TURNING 29.3/35 Revenue 67.7% · PAT 100% · OPM change 26.3 pp 83% evidence 15.9/25 ROCE 10.3% · OPM 46.2% 76% evidence 8.9/20 P/E 164.4× · PEG — 15% evidence 5.9/20 RS sector -15.6% · RS bench -6.3% · 1Y -13.1%1 of 12 weeks ahead 100% evidence
Exact sum: 29.3 + 15.9 + 8.9 + 5.9 = 60 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.6% and the one-year return is -13.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
6CrowdStrike Holdings, Inc.CRWD 55.7/100Mixed-positive evidence67% evidence LEADER 22.2/35 Revenue 23.2% · PAT — · OPM change 8.6 pp 71% evidence 6.5/25 ROCE -0.5% · OPM -2.2% 76% evidence 8.5/20 P/E 582.1× · PEG — 15% evidence 18.5/20 RS sector 32.3% · RS bench 46% · 1Y 99%12 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 6.5 + 8.5 + 18.5 = 55.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Okta, Inc.OKTA 54.4/100Mixed-positive evidence75% evidence BREAKING OUT 18.1/35 Revenue 11.8% · PAT 90% · OPM change 1.6 pp 95% evidence 8.2/25 ROCE 0.8% · OPM 7.3% 76% evidence 9.5/20 P/E 53.4× · PEG — 15% evidence 18.6/20 RS sector 27.6% · RS bench 40.8% · 1Y 61.6%12 of 12 weeks ahead 100% evidence
Exact sum: 18.1 + 8.2 + 9.5 + 18.6 = 54.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8F5, Inc.FFIV 53.7/100Thin evidence · provisional58% evidence LEADER 16.7/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence 14.2/25 ROCE 4.4% · OPM 22.1% 76% evidence 10.5/20 P/E 33.1× · PEG — 15% evidence 12.3/20 RS sector 6.8% · RS bench 18.3% · 1Y 28.1%12 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 14.2 + 10.5 + 12.3 = 53.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Toast, Inc.TOST 53.2/100Mixed-positive evidence71% evidence TURNING 25.0/35 Revenue 23.4% · PAT 100% · OPM change 3.5 pp 83% evidence 10.7/25 ROCE 5.9% · OPM 6.7% 76% evidence 9.9/20 P/E 40.8× · PEG — 15% evidence 7.6/20 RS sector -15.1% · RS bench -6% · 1Y -21.5%2 of 12 weeks ahead 100% evidence
Exact sum: 25 + 10.7 + 9.9 + 7.6 = 53.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10GoDaddy Inc.GDDY 52.0/100Thin evidence · provisional58% evidence ASLEEP 21.2/35 Revenue — · PAT — · OPM change 3.8 pp 45% evidence 15.3/25 ROCE 6.8% · OPM 24.5% 76% evidence 11.4/20 P/E 12.6× · PEG — 15% evidence 4.1/20 RS sector -33% · RS bench -26% · 1Y -33.2%1 of 12 weeks ahead 100% evidence
Exact sum: 21.2 + 15.3 + 11.4 + 4.1 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Microsoft CorporationMSFT 51.5/100Thin evidence · provisional58% evidence TURNING 16.7/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 16.2/25 ROCE 7.6% · OPM 46.3% 76% evidence 10.8/20 P/E 20.8× · PEG — 15% evidence 7.8/20 RS sector -11.2% · RS bench -1.5% · 1Y -5.6%2 of 12 weeks ahead 100% evidence
Exact sum: 16.7 + 16.2 + 10.8 + 7.8 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12DigitalOcean Holdings, Inc.DOCN 51.2/100Mixed-positive evidence71% evidence FADING 16.8/35 Revenue 17.7% · PAT 100% · OPM change -3.7 pp 83% evidence 10.7/25 ROCE 2.2% · OPM 14.2% 76% evidence 10.4/20 P/E 37.5× · PEG — 15% evidence 13.3/20 RS sector 35.2% · RS bench 50.5% · 1Y 290%11 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 10.7 + 10.4 + 13.3 = 51.2 · Decision use: Price leads the evidence: RS versus the benchmark is 50.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
13Nutanix, Inc.NTNX 50.6/100Mixed-positive evidence75% evidence BREAKING OUT 19.0/35 Revenue -1.9% · PAT 100% · OPM change 5.2 pp 95% evidence 11.0/25 ROCE 3.7% · OPM 19.3% 76% evidence 9.8/20 P/E 43× · PEG — 15% evidence 10.8/20 RS sector -6.3% · RS bench 2.9% · 1Y -14.1%11 of 12 weeks ahead 100% evidence
Exact sum: 19 + 11 + 9.8 + 10.8 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Rubrik, Inc.RBRK 50.1/100Mixed-positive evidence64% evidence BREAKING OUT 25.7/35 Revenue 45.9% · PAT — · OPM change 19.8 pp 71% evidence 3.1/25 ROCE -5.3% · OPM -13.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 11.3/20 RS sector -5.3% · RS bench 4.2% · 1Y -7.3%12 of 12 weeks ahead 100% evidence
Exact sum: 25.7 + 3.1 + 10 + 11.3 = 50.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Samsara Inc.IOT 49.3/100Mixed-negative evidence67% evidence BREAKING OUT 24.5/35 Revenue 29.6% · PAT — · OPM change 10.6 pp 71% evidence 7.1/25 ROCE 0.5% · OPM 1.5% 76% evidence 8.6/20 P/E 304.9× · PEG — 15% evidence 9.1/20 RS sector -9.4% · RS bench 0.2% · 1Y 14.4%7 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 7.1 + 8.6 + 9.1 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Gen Digital Inc.GEN 48.8/100Mixed-negative evidence74% evidence BREAKING OUT 17.4/35 Revenue 27.1% · PAT 51.3% · OPM change -6.4 pp 62% evidence 15.8/25 ROCE 6.3% · OPM 62.6% 76% evidence 7.1/20 P/E 12× · PEG 2.71 65% evidence 8.5/20 RS sector -9.5% · RS bench 0.1% · 1Y -7.2%9 of 12 weeks ahead 100% evidence
Exact sum: 17.4 + 15.8 + 7.1 + 8.5 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Cloudflare, Inc.NET 48.8/100Mixed-negative evidence61% evidence BREAKING OUT 18.0/35 Revenue 31.6% · PAT — · OPM change 1.4 pp 62% evidence 3.5/25 ROCE -1.9% · OPM -9.7% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 17.3/20 RS sector 14.6% · RS bench 26.9% · 1Y 47.3%8 of 12 weeks ahead 100% evidence
Exact sum: 18 + 3.5 + 10 + 17.3 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Twilio Inc.TWLO 47.7/100Mixed-negative evidence64% evidence FADING 18.5/35 Revenue 15.6% · PAT — · OPM change 5.7 pp 62% evidence 8.5/25 ROCE 1.2% · OPM 7.7% 76% evidence 8.8/20 P/E 196.6× · PEG — 15% evidence 11.9/20 RS sector 10.6% · RS bench 22.8% · 1Y 96.7%10 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 8.5 + 8.8 + 11.9 = 47.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Akamai Technologies, Inc.AKAM 45.7/100Mixed-negative evidence81% evidence FADING 10.0/35 Revenue 6.1% · PAT -4% · OPM change -4.5 pp 83% evidence 11.6/25 ROCE 1.2% · OPM 10.7% 76% evidence 15.2/20 P/E 38.7× · PEG 0.7 65% evidence 8.9/20 RS sector -0.7% · RS bench 10.8% · 1Y 74.9%8 of 12 weeks ahead 100% evidence
Exact sum: 10 + 11.6 + 15.2 + 8.9 = 45.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
20MongoDB, Inc.MDB 44.8/100Mixed-negative evidence64% evidence BREAKING OUT 20.9/35 Revenue 23.7% · PAT — · OPM change 6.2 pp 71% evidence 5.0/25 ROCE -0.8% · OPM -3.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.9/20 RS sector -6.3% · RS bench 4.2% · 1Y 81.7%10 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 5 + 10 + 8.9 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Check Point Software Technologies Ltd.CHKP 43.3/100Thin evidence · provisional58% evidence TURNING 13.9/35 Revenue — · PAT — · OPM change -3 pp 45% evidence 14.2/25 ROCE 3.8% · OPM 27.7% 76% evidence 11.2/20 P/E 13.5× · PEG — 15% evidence 4.0/20 RS sector -39.5% · RS bench -32.8% · 1Y -32.4%1 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 14.2 + 11.2 + 4 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Oracle Corporationthis pageORCL 42.2/100Mixed-negative evidence85% evidence ASLEEP 16.1/35 Revenue 17.4% · PAT 37.3% · OPM change -0.1 pp 95% evidence 13.1/25 ROCE 3.4% · OPM 32% 76% evidence 12.4/20 P/E 38.7× · PEG 1.13 65% evidence 0.6/20 RS sector -39.7% · RS bench -33.5% · 1Y -41.7%5 of 12 weeks ahead 100% evidence
Exact sum: 16.1 + 13.1 + 12.4 + 0.6 = 42.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Palo Alto Networks, Inc.PANW 40.1/100Mixed-negative evidence85% evidence LEADER 7.9/35 Revenue 19.5% · PAT -31.9% · OPM change -15.7 pp 95% evidence 6.8/25 ROCE -0.7% · OPM -6.1% 76% evidence 5.5/20 P/E 147× · PEG 2.62 65% evidence 19.9/20 RS sector 40.1% · RS bench 54.3% · 1Y 119.3%12 of 12 weeks ahead 100% evidence
Exact sum: 7.9 + 6.8 + 5.5 + 19.9 = 40.1 · Decision use: Price leads the evidence: RS versus the benchmark is 54.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
24Zscaler, Inc.ZS 35.8/100Mixed-negative evidence64% evidence FADING 16.4/35 Revenue 24.6% · PAT — · OPM change 0.2 pp 71% evidence 4.5/25 ROCE -0.9% · OPM -3.5% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 4.9/20 RS sector -35.7% · RS bench -29.3% · 1Y -39.5%3 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 4.5 + 10 + 4.9 = 35.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25CoreWeave, Inc.CRWV 33.9/100Adverse evidence61% evidence ASLEEP 16.0/35 Revenue 100% · PAT — · OPM change -4.2 pp 62% evidence 5.4/25 ROCE -0.5% · OPM -6.9% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 2.5/20 RS sector -23.5% · RS bench -15.1% · 1Y -29.1%6 of 12 weeks ahead 100% evidence
Exact sum: 16 + 5.4 + 10 + 2.5 = 33.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Block, Inc.XYZ 31.0/100Adverse evidence71% evidence BREAKING OUT 5.2/35 Revenue 2.3% · PAT -68.8% · OPM change -8.5 pp 83% evidence 6.5/25 ROCE -0.6% · OPM -2.8% 76% evidence 9.6/20 P/E 47× · PEG — 15% evidence 9.7/20 RS sector -1.2% · RS bench 9.4% · 1Y 15.3%9 of 12 weeks ahead 100% evidence
Exact sum: 5.2 + 6.5 + 9.6 + 9.7 = 31 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Synopsys, Inc.SNPS 30.4/100Adverse evidence85% evidence ASLEEP 10.3/35 Revenue 39.5% · PAT -41.8% · OPM change -18.2 pp 95% evidence 9.8/25 ROCE 0.4% · OPM 5.3% 76% evidence 8.4/20 P/E 111.7× · PEG 1.75 65% evidence 1.9/20 RS sector -29.2% · RS bench -21.4% · 1Y -34.8%1 of 12 weeks ahead 100% evidence
Exact sum: 10.3 + 9.8 + 8.4 + 1.9 = 30.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Cerebras Systems Inc.CBRS 49.8/100Thin evidence · provisional41% evidence 25.6/35 Revenue 86.1% · PAT — · OPM change 20.8 pp 62% evidence 4.2/25 ROCE -0.9% · OPM -7.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 25.6 + 4.2 + 10 + 10 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Oracle Corporation's stock price today?

Oracle Corporation trades at $146, −40.4% over the past year. The company is valued at $420 B. The stock sits at 16% of its 52-week range of $115–$309, −19.7% versus its 200-day average. On the tape, the price is in a downtrend, 9 weeks in. — as of 5 August 2026.

What were Oracle Corporation's latest quarterly results?

Oracle Corporation reported revenue of $19.2 B and net profit of $4.3 B for the May 26 quarter. Revenue rose 20.6% and profit rose 25.4% year on year. Earnings per share were $1.45. The operating margin was 32.0%, 0.1 pp lower than a year earlier. — as of 5 August 2026.

What is Oracle Corporation's revenue?

Oracle Corporation reported revenue of $19.2 B in the May 26 quarter, +20.6% year on year. For the full FY26 fiscal year, revenue was $67.4 B (+17.4%). Over the last 4 years revenue compounded at 12.2% a year. — as of 5 August 2026.

What is Oracle Corporation's profit?

Oracle Corporation earned $4.3 B of net profit in the May 26 quarter, +25.4% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was $17.1 B. The operating margin ran 32.0% in the latest quarter. — as of 5 August 2026.

What is Oracle Corporation's market cap?

Oracle Corporation's market capitalisation is $420 B at a stock price of $146. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is Oracle Corporation's P/E ratio?

Oracle Corporation trades at a P/E of 25.0×, at the 3rd percentile of its own 4-year range, against a long-run median of 34.3×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does Oracle Corporation pay a dividend?

Yes — Oracle Corporation declared $0.50 per share for May 26, and $2.00 per share across the last four reported quarters. The latest quarter is up 25.0% on the same quarter a year earlier. — as of 5 August 2026.

What is Oracle Corporation's dividend per share?

Oracle Corporation's most recently declared dividend is $0.50 per share for May 26, giving $2.00 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.

What is Oracle Corporation's dividend yield?

Oracle Corporation's trailing dividend yield is 1.37%: $2.00 declared per share across the last four reported quarters, against a share price of $146. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.

Is Oracle Corporation overvalued?

On its own history, Oracle Corporation looks cheap against its own history: its P/E of 25.0× has been cheaper only 3% of the time in 4 years (long-run median 34.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.

Is Oracle Corporation growing?

Yes — Oracle Corporation is growing: latest-quarter revenue +20.6% year on year, profit +25.4%, and the margin −0.1 pp at 32.0%. The 4-year compound rates are 12.2% (revenue) and 26.3% (profit). The earnings engine currently reads: improving — as of 5 August 2026.

How is Oracle Corporation performing?

Oracle Corporation is in a downtrend, 9 weeks in. Its latest quarter's revenue rose 20.6% and profit rose 25.4% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is Oracle Corporation in?

Mixed — the growth curves are steadily positive, but ROCE at 11.6% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +17.4% latest, profit growth +37.2% latest, eps growth +34.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is Oracle Corporation in an uptrend?

No — the price is in a downtrend (week 9 of stage 4), trading −19.7% versus its 200-day average and at 16% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is Oracle Corporation beating the market?

Not lately — on a trailing-13-week view Oracle Corporation is currently behind the S&P 500 (7 weeks and counting; last ahead the week of 2026-06-18), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +257% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.

Will Oracle Corporation's stock price go up?

This page publishes no price forecast for Oracle Corporation. What it measures instead: the stock price is $146, the price is in a downtrend 9 weeks in. Its P/E of 25.0× sits at the 3rd percentile of its own 4-year range. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against Oracle Corporation?

Somewhat — short interest is 2.9% of Oracle Corporation's tradable float, about 1.4 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

Does Oracle Corporation have too much debt?

It carries real leverage — Oracle Corporation's debt-to-equity is 3.89. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.

What is Oracle Corporation's capex?

Oracle Corporation spent $84.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $55.7 B. — as of 5 August 2026.

What is Oracle Corporation's cash flow?

Oracle Corporation generated $32.0 B of operating cash flow in FY26 and $−23.7 B of free cash flow after $55.7 B of capital spending. Reported profit that year was $17.1 B, so operating cash ran ahead of profit. — as of 5 August 2026.

Is Oracle Corporation's profit real cash?

Yes — over the last 3 fiscal years, 179% of Oracle Corporation's reported profit arrived as operating cash. In FY26, operating cash was $32.0 B against reported profit of $17.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is Oracle Corporation?

On the balance sheet, the Z-score reads 2.18 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.

Where is Oracle Corporation in its business cycle?

Oracle Corporation's FY26 operating margin was 30.6%, against a 5-year band of 25.8%–30.8%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 32.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Oracle Corporation story?

The sharpest disagreement: annual EPS moved +34.3% against a −40.4% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Oracle Corporation a stock worth studying right now?

This is not investment advice. The machine read: Oracle Corporation's earnings have outrun its stock. EPS grew +34.3% in a year against a −40.4% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI